Cidara Therapeutics
Cidara Therapeutics is developing innovative therapies.
Market cap
$1.0b
Enterprise value
$870m
Share price
$48.71 CDTX
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor investor investor investor | €0.0 | round | |
* | N/A | $350m | Post IPO Equity |
| Total Funding | 000k | ||
CARB-X(exited)
Square 1 Bank(exited)
5AM Ventures(exited)
Aisling Capital(exited)
Frazier Healthcare Partners(exited)
InterWest Partners(exited)
National Institutes of Health(exited)
Omega Funds(exited)
RA Capital Management(exited)
Frazier Life Sciences(exited)
Bain Capital Life Sciences(exited)
Venrock(exited)
Vivo Capital(exited)
BVF Partners(exited)
TCGX(exited)
Checkpoint Capital(exited)
Spruce Street Capital(exited)
Adage Capital(exited)
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 311 % | 30 % | (1 %) | (98 %) | - | - | 20 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (85 %) | (46 %) | (38 %) | (13794 %) | - | (4120 %) | (3816 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (86 %) | (46 %) | (36 %) | (13320 %) | - | (4739 %) | (4182 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 147 % | 117 % | 107 % | 12295 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.